Recent Insider Transactions • May 25
MD, CEO & Director recently sold AU$1.1m worth of stock On the 18th of May, Nicolas Hamilton sold around 120k shares on-market at roughly AU$9.15 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth AU$1.5m. Nicolas has been a net seller over the last 12 months, reducing personal holdings by AU$2.6m. Annuncio • Feb 17
Challenger Limited Announces Interim Dividend for the Year Ended 31 December 2025, Payable on 24 March 2026 Challenger Limited announced the 100% franked interim dividend of 15.5 cents (2024 interim: 14.5 cents per share) per share for the year ended 31 December 2025, payable on 24 March 2026. Ex-dividend date is on 24 February 2026 with Record date on 25 February 2026. Annuncio • Dec 17
Challenger Limited, Annual General Meeting, Oct 29, 2026 Challenger Limited, Annual General Meeting, Oct 29, 2026. Annuncio • Oct 16
Challenger Limited Reaffirms Earnings Guidance for the Year 2026 Challenger Limited reaffirmed earnings guidance for the year 2026. For the year, the company expects normalised basic EPS guidance range of between 66 and 72 cents per share. Declared Dividend • Aug 21
Final dividend of AU$0.15 announced Shareholders will receive a dividend of AU$0.15. Ex-date: 26th August 2025 Payment date: 18th September 2025 Dividend yield will be 3.4%, which is lower than the industry average of 3.7%. Sustainability & Growth Dividend is not covered by earnings (105% earnings payout ratio). However, it is covered by cash flows (51% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 17% to bring the payout ratio under control. EPS is expected to grow by 64% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Aug 19
Full year 2025 earnings released: EPS: AU$0.28 (vs AU$0.20 in FY 2024) Full year 2025 results: EPS: AU$0.28 (up from AU$0.20 in FY 2024). Revenue: AU$3.10b (down 5.3% from FY 2024). Net income: AU$192.3m (up 43% from FY 2024). Profit margin: 6.2% (up from 4.1% in FY 2024). The increase in margin was driven by lower expenses. Revenue is expected to fall by 31% p.a. on average during the next 3 years compared to a 6.7% decline forecast for the Diversified Financial industry in Australia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Apr 17
Challenger Limited Tightens Earnings Guidance for the Fiscal Year 2025 Challenger Limited tightened earnings guidance for the fiscal year 2025. For the year, the company has tightened its normalised net profit after tax guidance to a range of between $450 million and $465 million, with the mid-point of the range representing 10% growth on FY24. Annuncio • Apr 01
Challenger Limited Announces Resignation of Hiroyuki Iioka as Alternate Director to Mr. Masahiko Kobayashi, Effective on 31 March 2025 Mr. Hiroyuki Iioka has notified Challenger Limited of his resignation as Alternate Director to Mr. Masahiko Kobayashi effective on 31 March 2025 following his retirement on the same date from his position at MS&AD Insurance Group
Holdings Inc. Annuncio • Oct 24
Challenger Limited Announces Full Year Dividend for 2024 Reflecting the business's strong financial performance, the Board of Challenger Limited determined a full year dividend of $0.265 per share, an increase of 10% on last year. Buy Or Sell Opportunity • Oct 16
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.7% to AU$6.54. The fair value is estimated to be AU$8.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Earnings per share has declined by 51%. For the next 3 years, revenue is forecast to decline by 31% per annum. Earnings are forecast to grow by 22% per annum over the same time period. Annuncio • Sep 20
Matthew Michelini Steps Down from Challenger Limited Board Challenger Limited announced that Mr. Matthew Michelini has stepped down as Apollo Global Asset Management's representative on the Challenger Limited Board. The resignation follows the reduction in Apollo's ownership in Challenger, which has fallen below the previously disclosed condition for Apollo to hold a minimum of 15% of issued capital to maintain its seat on the Challenger Limited Board. Mr. Michelini's resignation is effective immediately. Buy Or Sell Opportunity • Aug 23
Now 21% undervalued Over the last 90 days, the stock has risen 8.1% to AU$7.17. The fair value is estimated to be AU$9.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Earnings per share has declined by 51%. For the next 3 years, revenue is forecast to decline by 28% per annum. Earnings are forecast to grow by 21% per annum over the same time period. Reported Earnings • Aug 14
Full year 2024 earnings released: EPS: AU$0.19 (vs AU$0.43 in FY 2023) Full year 2024 results: EPS: AU$0.19 (down from AU$0.43 in FY 2023). Revenue: AU$2.93b (up 23% from FY 2023). Net income: AU$134.5m (down 55% from FY 2023). Profit margin: 4.6% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is expected to fall by 25% p.a. on average during the next 3 years compared to a 7.4% decline forecast for the Diversified Financial industry in Australia. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Aug 06
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at AU$6.51. The fair value is estimated to be AU$8.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 16% per annum. Earnings are forecast to grow by 14% per annum over the same time period. Annuncio • Apr 30
Heartland Group Holdings Limited (NZSE:HGH) completed the acquisition of Challenger Bank Limited from Challenger Limited (ASX:CGF) Heartland Group Holdings Limited (NZSE:HGH) signed a conditional share purchase agreement for the purchase of Challenger Bank Limited from Challenger Limited (ASX:CGF) for AUD 36 million on October 20, 2022. Upon completion Heartland’s existing Reverse Mortgage and Livestock businesses in Australia will be transferred to sit in or under Challenger Bank. For regulatory reasons, Heartland will be required to hold Challenger Bank through an Australian incorporated non-operating holding company (NOHC) which is approved and regulated by the Australian Prudential Regulatory Authority. Heartland’s intention is to cover the costs of the acquisition through existing resources. The share purchase agreement is subject to obtaining the requisite regulatory approvals in Australia and New Zealand. Corrs Chambers Westgarth acted as legal advisor, Jarden Partners Limited acted as financial advisor and Deloitte & Touche Netherlands acted as accountant to Heartland Group Holdings Limited. Deal is expected to settle in 2H23. In April 2023, Challenger received approval from APRA to release AUD 50 million of excess Bank capital, which was injected into Challenger Life. The remaining excess capital of approximately AUD 40 million is expected, subject to regulatory approvals in Australia and New Zealand, to be returned
to Challenger prior to or on completion of the sale providing additional financial flexibility to support growth in the Life business. As of August 15, 2023, the transaction is expected to complete in H1, 2024. As of April 8, 2024
Challenger Bank Limited has received indictive approval from Australian Prudential Regulation Authority and the Reserve Bank of New Zealand subject to Heartland receiving final regulatory approvals from APRA and the RBNZ and is expected to complete by April 30, 2024.
Heartland Group Holdings Limited (NZSE:HGH) completed the acquisition of Challenger Bank Limited from Challenger Limited (ASX:CGF) on April 30, 2024. Reported Earnings • Feb 16
First half 2024 earnings released: EPS: AU$0.087 (vs AU$0.054 in 1H 2023) First half 2024 results: EPS: AU$0.087 (up from AU$0.054 in 1H 2023). Revenue: AU$1.48b (up 67% from 1H 2023). Net income: AU$59.3m (up 62% from 1H 2023). Profit margin: 4.0% (down from 4.1% in 1H 2023). Revenue is expected to fall by 21% p.a. on average during the next 3 years compared to a 8.0% decline forecast for the Diversified Financial industry in Australia. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 3% per year. Declared Dividend • Feb 16
First half dividend increased to AU$0.13 Dividend of AU$0.13 is 8.3% higher than last year. Ex-date: 20th February 2024 Payment date: 19th March 2024 Dividend yield will be 3.5%, which is lower than the industry average of 3.7%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (35% cash payout ratio). The dividend has increased by an average of 2.7% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 53% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Feb 13
Challenger Limited Declares Interim Dividend for the Six Months Ended 31 December 2023, Payable on 19 March 2024 The Challenger Board has declared a fully franked interim dividend of 13.0 cents for the six months ended 31 December 2023 compared to 12.00 cents paid for the same period a year ago. Record date is 21 February 2022. Ex-dividend date is 20 February 2024. The dividend will be paid on 19 March 2024. Annuncio • Dec 01
Challenger Limited Announces Quarterly Dividend Ended February 26, 2024, Payable on February 25, 2024 Challenger Limited announced dividend on CAP NOTE 3-BBSW+4.60% PERP NON-CUM RED T-05-26 of AUD 1.57000000 relates to a period of one quarter ended February 25, 2024. Record Date is February 16, 2023. Ex Date is February 15, 2024. Payment Date is February 26, 2024. Annuncio • Nov 11
Challenger Limited Appoints Matthew Michelini as Director Challenger Limited appointed Matthew Michelini as director, Date of appointment is 9 November 2023. Annuncio • Nov 09
Challenger Limited and Challenger Life Company Limited Announce the Appointment of Lisa Gray as Independent Non-Executive Director, Effective 9 November 2023 Challenger Limited announced the appointment of Lisa Gray as an independent Non-Executive Director of both Challenger Limited and Challenger Life Company Limited, effective from 9 November 2023. Lisa Gray has over 30 years' experience in leading large businesses across banking, investment management, superannuation, insurance and wealth management. She is an experienced non-executive director and currently serves on the boards of ING Bank (Australia) Limited and Victorian Funds Management Corporation. Previously, Ms Gray was Chief Executive of Victorian Funds Management Corporation. She has also held senior executive roles at NAB including Group Executive, Enterprise Services and Transformation, and Group Executive, Personal Banking. Prior to this, Ms Gray served as Chief Executive of MLC Insurance and Managing Director Plum Financial Services. Ms Gray's qualifications include an Advanced Management Program from INSEAD, an MBA from the University of Melbourne and Columbia University (USA), a Graduate Diploma in Management and a Bachelor of Town and Regional Planning (Hons). Ms Gray will stand for election at Challenger's Annual General Meeting in October 2024. Annuncio • Sep 26
Challenger Limited Announces Board Changes Challenger Limited announced that Mr. Steven Gregg will retire from the Board of Challenger Limited at the Annual General Meeting on 26 October 2023. Mr. Gregg has served as an independent Non-executive Director since 2012. In that time, he has served on a range of committees, including as Chair of the Group Audit Committee and as a member of the Group Remuneration, Group Risk and Nomination Committees. Annuncio • Sep 14
Challenger Limited Declares Ordinary Dividend for the Six Months Period Ended 30 June 2023, Payable on 20 September 2023 Challenger Limited declared ordinary dividend of AUD 0.12000000 for the six months period ended 30 June 2023. Record Date is on 29 August 2023, Ex date is on 28 August 2023 and Payment date is on 20 September 2023. Upcoming Dividend • Aug 21
Upcoming dividend of AU$0.12 per share at 3.6% yield Eligible shareholders must have bought the stock before 28 August 2023. Payment date: 20 September 2023. Payout ratio is a comfortable 55% and this is well supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Australian dividend payers (7.2%). Higher than average of industry peers (3.2%). Reported Earnings • Aug 15
Full year 2023 earnings released: EPS: AU$0.42 (vs AU$0.38 in FY 2022) Full year 2023 results: EPS: AU$0.42 (up from AU$0.38 in FY 2022). Revenue: AU$2.46b (up 389% from FY 2022). Net income: AU$295.5m (up 17% from FY 2022). Profit margin: 12% (down from 50% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to decline by 21% p.a. on average during the next 3 years, while revenues in the Diversified Financial industry in Australia are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Annuncio • Jul 08
Elanor Investors Limited and Elanor Investment Fund completed the acquisition of Challenger Real Estate from Challenger Limited. Elanor Investors Limited and Elanor Investment Fund have entered into agreement to acquire Challenger Real Estate from Challenger Limited for AUD 41.8 million on April 6, 2023. Elanor will issue 27.4 million securities to Challenger as consideration for the acquisition of Challenger Real Estate. The Consideration is subject to claw-back provisions based on certain milestones, including minimum base funds management fee targets. Post-transaction, Challenger will be Elanor’s largest securityholder with an 18.2% holding. Completion is subject to certain conditions, including Elanor Investors Group securityholder approval and other regulatory approvals. The transaction is expected to complete on June 30, 2023.Transaction expected to deliver material earnings accretion in FY24. As of May 29, 2023, Elanor has been advised by Challenger that one third party institutional mandate will not transfer and as such, the Purchase Price for CRE has been reduced to AUD 37.7 million from AUD 41.8 million. EIL will issue up to 24,754,165 EIL shares and procure EFML to issue up to 24,754,165 EIF units to Challenger Limited as consideration for the acquisition of CRE, representing up to 16.7% of ENN Securities on issue. Elanor will become Challenger Life Company Limited’s commercial real estate partner in Australia and New Zealand, managing a AUD 2.7 billion portfolio of real estate assets. EIL and EIF announces a Extraordinary General Meetings of shareholders and unitholders, respectively will be held on June 30, 2023. Moelis Australia Securities Pty Ltd. acted as financial advisor to Elanor Investors Limited.
Elanor Investors Limited and Elanor Investment Fund completed the acquisition of Challenger Real Estate from Challenger Limited on July 7, 2023. Elanor has also secured the transfer of the institutional mandate with a subsidiary of Abu Dhabi Investment Council (ADIC) as part of its acquisition of CRE. As part of the transfer of the ADIC mandate, Challenger has transferred 4.5 million of the 24.8 million new securities in Elanor to ADIC resulting in Challenger’s and ADIC’s holding in Elanor representing approximately 13.6% and 3.0% of total Elanor securities on issue, respectively. Recent Insider Transactions • May 04
Independent Non-Executive Director recently bought AU$62k worth of stock On the 1st of May, Heather Smith bought around 10k shares on-market at roughly AU$6.17 per share. This transaction amounted to 53% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth AU$101k. Insiders have collectively bought AU$162k more in shares than they have sold in the last 12 months. Recent Insider Transactions • Apr 28
Independent Non-Executive Chairman recently bought AU$101k worth of stock On the 21st of April, Duncan West bought around 16k shares on-market at roughly AU$6.28 per share. This transaction amounted to 62% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Duncan's only on-market trade for the last 12 months. Buying Opportunity • Mar 20
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be AU$7.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Earnings per share has grown by 34%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings is also forecast to grow by 20% per annum over the same time period. Annuncio • Feb 16
Challenger Limited Declares Ordinary Dividend for the Six Months Period Ended 31 December 2022, Payable on 21 March 2023 Challenger Limited declared ordinary dividend of AUD 0.12000000 for the six months period ended 31 December 2022. Record Date is on 22 February 2023, Ex date is on 21 February 2023 and Payment date is on 21 March 2023. Reported Earnings • Feb 16
First half 2023 earnings released: EPS: AU$0.18 (vs AU$0.42 in 1H 2022) First half 2023 results: EPS: AU$0.18 (down from AU$0.42 in 1H 2022). Revenue: AU$1.51b (up 2.2% from 1H 2022). Net income: AU$128.2m (down 55% from 1H 2022). Profit margin: 8.5% (down from 19% in 1H 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Australia. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Buying Opportunity • Feb 12
Now 20% undervalued Over the last 90 days, the stock is up 1.7%. The fair value is estimated to be AU$9.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 15% per annum. Earnings is also forecast to grow by 17% per annum over the same time period. Buying Opportunity • Oct 01
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be AU$7.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings is also forecast to grow by 13% per annum over the same time period. Upcoming Dividend • Aug 22
Upcoming dividend of AU$0.12 per share Eligible shareholders must have bought the stock before 29 August 2022. Payment date: 21 September 2022. Payout ratio is a comfortable 61% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of Australian dividend payers (6.3%). In line with average of industry peers (3.3%). Reported Earnings • Aug 19
Full year 2022 earnings released: EPS: AU$0.38 (vs AU$0.88 in FY 2021) Full year 2022 results: EPS: AU$0.38 (down from AU$0.88 in FY 2021). Revenue: AU$705.8m (down 80% from FY 2021). Net income: AU$253.7m (down 57% from FY 2021). Profit margin: 36% (up from 17% in FY 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 21% compared to a 53% decline forecast for the Diversified Financial industry in Australia. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Buying Opportunity • Jul 17
Now 21% undervalued Over the last 90 days, the stock is up 2.5%. The fair value is estimated to be AU$8.90, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings is also forecast to grow by 9.9% per annum over the same time period. Buying Opportunity • Jun 18
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 9.2%. The fair value is estimated to be AU$8.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 0.8% per annum. Earnings is also forecast to grow by 6.0% per annum over the same time period. Reported Earnings • Feb 20
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat First half 2022 results: EPS: AU$0.42 (up from AU$0.33 in 1H 2021). Revenue: AU$1.47b (up 15% from 1H 2021). Net income: AU$282.0m (up 27% from 1H 2021). Profit margin: 19% (up from 17% in 1H 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.8%. Over the next year, revenue is expected to shrink by 77% compared to a 102% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Board Change • Oct 31
High number of new directors Independent Non-Executive Director Heather Smith was the last director to join the board, commencing their role in 2021. Recent Insider Transactions • Sep 28
MD, CEO & Director recently sold AU$3.4m worth of stock On the 23rd of September, Richard Howes sold around 545k shares on-market at roughly AU$6.18 per share. This was the largest sale by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months. Upcoming Dividend • Aug 23
Upcoming dividend of AU$0.10 per share Eligible shareholders must have bought the stock before 30 August 2021. Payment date: 22 September 2021. Trailing yield: 3.3%. Lower than top quartile of Australian dividend payers (5.1%). Higher than average of industry peers (2.6%). Reported Earnings • Aug 11
Full year 2021 earnings released: EPS AU$0.88 (vs AU$0.68 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$2.79b (up 55% from FY 2020). Net income: AU$592.3m (up AU$1.01b from FY 2020). Profit margin: 21% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Annuncio • Apr 20
Challenger Reaffirms Earning Guidance for the Year 2021 Challenger reaffirmed earning guidance for the year 2021. The company's normalised net profit before tax guidance, however, now expects to be at the bottom end of the $390 million and $440 million guidance range.
Earnings reflect the sharp decline in credit spreads over the year, which were not fully reflected in customer pricing. Challenger is responding to the investment conditions by significantly adjusting annuity pricing. Annuncio • Mar 11
Challenger Limited Announces Executive Changes, Effective on March 15, 2020 Challenger Limited announced the appointment of Ms. Angela Murphy to the role of Chief Executive Life following the decision to combine its Life and Distribution, Product and Marketing (DPM) teams. The Life business will continue to sit alongside Funds Management and the recently acquired Bank 1 business, creating three clear business lines with the focus and capabilities to drive strong commercial outcomes. Each business will continue to be supported by an efficient shared services model, including investment and client operations, technology and corporate functions. Ms. Murphy has held a variety of executive roles including Chief Operating Officer DPM before her appointment as Chief Executive DPM in December 2018. As Chief Executive DPM, Ms. Murphy is a member of Challenger's leadership team and has been responsible for the strategic direction and delivery of Life's distribution, product and marketing functions. Following these executive changes, Mr. Anton Kapel will resume his previous role as Challenger's Appointed Actuary and Chief Financial Officer of the Life business. Mr. Howes thanked Mr. Kapel for his contribution as Acting Chief Executive for the Life business. These changes will take effect on 15 March 2020. Recent Insider Transactions • Mar 02
Independent Non-Executive Director recently bought AU$67k worth of stock On the 25th of February, Heather Smith bought around 10k shares on-market at roughly AU$6.67 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.0m more in shares than they have sold in the last 12 months. Annuncio • Mar 01
Challenger Announces Chief Financial Officer Changes Challenger Limited announced the appointment of Ms Rachel Grimes as Chief Financial Officer, effective 3 May 2021. She is currently General Manager, Finance, Westpac Banking Corporation and has held a number of senior finance roles across the Westpac Group. Ms Grimes replaces Mr. Andrew Tobin, who is stepping down after 13 years at Challenger. Upcoming Dividend • Feb 17
Upcoming Dividend of AU$0.095 Per Share Will be paid on the 23rd of March to those who are registered shareholders by the 23rd of February. The trailing yield of 3.0% is below the top quartile of Australian dividend payers (5.1%), and is lower than industry peers (4.8%). Reported Earnings • Feb 10
First half 2021 earnings released: EPS AU$0.33 (vs AU$0.36 in 1H 2020) The company reported a solid first half result with improved earnings and revenues, although profit margins were flat. First half 2021 results: Revenue: AU$1.29b (up 6.3% from 1H 2020). Net income: AU$222.8m (up 1.1% from 1H 2020). Profit margin: 17% (in line with 1H 2020). Over the last 3 years on average, earnings per share has fallen by 76% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 06
New 90-day high: AU$7.25 The company is up 46% from its price of AU$4.95 on 06 November 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$6.00 per share. Annuncio • Jan 22
Michael Vardanega Steps Down as Company Secretary of Challenger Limited Challenger Limited announced that Mr. Michael Vardanega has stepped down from the position of company Secretary in order to lead the integration of MyLifeMyFinance Limited. This change is effective immediately with Ms Linda Mat hews continuing as Chal enger's company Secretary. Annuncio • Jan 21
Challenger Limited Announces the Appointment of Heather Smith as an Independent Non-Executive Director of Both Challenger Limited and Challenger Life Company Limited Challenger Limited announced the appointment of Dr. Heather Smith as an independent Non-Executive Director of both Challenger Limited and Challenger Life Company Limited, effective immediately. Dr. Smith has over 20 years' experience in government and most recently held the position of Secretary of theFederalDepartment of Industry, Innovation and Science.Prior to that she was Secretary of the Department of Communication and the Arts and Deputy Secretary of the Department of Prime Minister and Cabinet. Is New 90 Day High Low • Jan 07
New 90-day high: AU$6.81 The company is up 61% from its price of AU$4.22 on 09 October 2020. The Australian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$5.82 per share. Annuncio • Jan 04
Challenger Limited Announces Executive Changes Challenger Limited announced that Mr. Andrew Brown has resigned from the position of Company Secretary and Ms. Linda Matthews has been appointed to the position of Company Secretary. The changes were effective 1 January 2020. Is New 90 Day High Low • Dec 24
New 90-day high: AU$6.50 The company is up 73% from its price of AU$3.76 on 25 September 2020. The Australian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$6.12 per share. Annuncio • Dec 23
Challenger Limited (ASX:CGF) entered into an agreement to acquire Mylifemyfinance Limited from MyLifeMyMoney Superannuation Fund. for AUD 35 million. Challenger Limited (ASX:CGF) entered into an agreement to acquire Mylifemyfinance Limited from MyLifeMyMoney Superannuation Fund. for AUD 35 million on December 23, 2020. Challenger will hold an Australian Prudential Regulation Authority (APRA) authorized deposit-taking institution (ADI) license. The acquisition price and capital requirements, including regulatory capital to support growth, will be funded by a AUD 100 million distribution from Challenger Life Company Limited (CLC) during the March, 2021 quarter. Mylifemyfinance Limited had net asset value of AUD 18 million. The acquisition is subject to approval by both APRA and the Federal Treasurer. The acquisition is expected to settle in late March, 2021. Is New 90 Day High Low • Dec 05
New 90-day high: AU$5.97 The company is up 51% from its price of AU$3.96 on 04 September 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$4.85 per share. Annuncio • Nov 30
Challenger Limited Announces Executive Changes, Effective December 7, 2020 Challenger Limited announced the appointment of long-standing Challenger executive Chris Plater to the newly created role of Chief Executive, Operations and Technology. The appointment of Mr. Plater reflects the importance of operations and technology in implementing Challenger's growth strategy. A dedicated executive will now be responsible for these critical functions, with operations and technology previously reporting to Challenger's Chief Financial Officer. Mr. Plater joined Challenger in 2003 and has served in a variety of key leadership roles, with the most recent being Chief Executive of the Life business for the past four years. Mr. Plater will continue to be a member of Challenger's Leadership Team and will continue to support the Life business, including remaining Chair of Life's Investment Committee. Anton Kapel, currently Challenger's Appointed Actuary and Chief Financial Officer of the Life business, will take on the role of Acting Chief Executive of the Life business while an executive search is undertaken. These executive changes will be effective from 7 December 2020. Is New 90 Day High Low • Nov 10
New 90-day high: AU$5.08 The company is up 27% from its price of AU$3.99 on 12 August 2020. The Australian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$8.02 per share. Is New 90 Day High Low • Oct 20
New 90-day high: AU$4.69 The company is up 1.0% from its price of AU$4.65 on 22 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$8.82 per share. Annuncio • Sep 30
Challenger Limited Announces Resignation of Andrew Tobin, CFO in March 2021 Challenger Limited announced that Chief Financial Officer, Andrew Tobin, has provided six months' notice of his resignation and will leave the business in March 2021. Annuncio • Jul 24
Challenger Limited has completed a Follow-on Equity Offering in the amount of AUD 34.992 million. Challenger Limited has completed a Follow-on Equity Offering in the amount of AUD 34.992 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 8,100,000
Price\Range: AUD 4.32 
